XML 28 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Additional Paid In Capital
Cumulative Net Income
Cumulative Net Income
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Distributions
Beginning balance (in shares) at Dec. 31, 2022     14,709,000        
Beginning balance at Dec. 31, 2022 $ 271,579 $ (6,595) $ 15 $ 238,505 $ 52,290 $ (6,595) $ (19,231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share grants (in shares)     122,000        
Share grants $ 1,124     1,124      
Share repurchases (in shares) (17,421)   (17,000)        
Share repurchases $ (183)     (183)      
Share forfeitures (in shares)     (3,000)        
Share forfeitures (3)     (3)      
Net income 25,965       25,965    
Distributions $ (20,639)           (20,639)
Ending balance (in shares) at Dec. 31, 2023 14,811,410   14,811,000        
Ending balance at Dec. 31, 2023 $ 271,248   $ 15 239,443 71,660   (39,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share grants (in shares)     120,000        
Share grants $ 1,359     1,359      
Share repurchases (in shares) (28,165)   (28,000)        
Share repurchases $ (377)     (377)      
Net income 17,820       17,820    
Distributions $ (20,772)           (20,772)
Ending balance (in shares) at Dec. 31, 2024 14,902,773   14,903,000        
Ending balance at Dec. 31, 2024 $ 269,278   $ 15 $ 240,425 $ 89,480   $ (60,642)